CASTLEARK MANAGEMENT LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
CASTLEARK MANAGEMENT LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,259,943
+235.8%
90,980
+350.2%
0.10%
+292.3%
Q3 2021$673,000
-91.6%
20,211
-90.2%
0.03%
-90.3%
Q2 2021$8,020,000
-23.5%
206,761
-5.0%
0.27%
-28.8%
Q1 2021$10,490,000
+32.7%
217,631
+43.3%
0.38%
+27.7%
Q4 2020$7,903,000
+135.8%
151,916
+21.3%
0.30%
+126.0%
Q3 2020$3,351,000125,2100.13%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders